As every year in June, the AFI Symposium, the Italian conference dedicated to the pharmaceutical sector, will be held. From 5 to 7 June 2019 at the Rimini conference center, issues will be discussed with the theme “Innovation and globalization strategies for the pharmaceutical industry”.

There will be 17 Scientific Sessions, which will cover topics from all areas of the pharmaceutical sector: from research to development, from production to the distribution of medicines and medical devices.

Regarding pharmacovigilance, on the morning of Thursday 6 June, more precisely from 11:00 to 13:00, will be held, in the “Sala della Piazza”, the Scientific Session VII entitled “New horizons of pharmacovigilance“. Since innovation is the main theme of this year, the debate can only turn to innovative, biological and biosimilar medicines. The pharmacovigilance activities to be performed in the presence of this type of drug will be detailed and signal management will be deepened, analyzing the parameters, criteria and difficulties.

Moderators: Anna Rosa Marra of AIFA and Andrea Oliva of Mylan
11:00 – 11:15 Introduction of the AFI working group – Pharmacovigilance – Andrea Oliva – AFI and Mylan
11:15 – 11:40 Analysis and management of a pharmacovigilance signal – Gianluca Trifirò – University of Messina
11:40 – 12:05 Pharmacovigilance in biological and biosimilar drugs – Annalisa Iezzi – Abbvie and Assobiotec
12:05 – 12:50 Round table: new horizons of pharmacovigilance – Annalisa Iezzi – Abbvie and Assobiotec, Anna Rosa Marra – AIFA, Andrea Oliva – AFI and Mylan, Giovanna Pescatore – Farmindustria, Gianluca Trifirò – University of Messina, Romina Tulimiero of AFI and Assogenerici
12:50 – 13:00 Debate and conclusions of the work
13:00 – 14:00 Business lunch

Also, on Thursday there will be a speech dedicated to pharmacovigilance within the Piazza for the future and employment of young people, held by Paolo Biffignandi of AFI and VI.REL Pharma, aimed at university students and new graduates.

We also inform you that on the morning of Wednesday, June 5, entirely dedicated to the workshops, one relating to pharmacovigilance will be held, entitled “The risk-based approach in pharmacovigilance audits: from the planning of the strategic audit plan to the detection of non-compliance”.

For those who, instead, were looking for a native ICH R3 database for pharmacovigilance management, will find SafetyDrugs at stand 36.